These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20086232)

  • 1. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
    Conti R; Veenstra DL; Armstrong K; Lesko LJ; Grosse SD
    Med Decis Making; 2010; 30(3):328-40. PubMed ID: 20086232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating genomics in cancer care.
    Bombard Y; Bach PB; Offit K
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness, personalized medicine and innovation: the path forward.
    Thomas A; Phillips A; Donnelly R; Piech CT
    Pharmacoeconomics; 2010; 28(10):923-30. PubMed ID: 20831300
    [No Abstract]   [Full Text] [Related]  

  • 4. Toward clinical genomics in everyday medicine: perspectives and recommendations.
    Delaney SK; Hultner ML; Jacob HJ; Ledbetter DH; McCarthy JJ; Ball M; Beckman KB; Belmont JW; Bloss CS; Christman MF; Cosgrove A; Damiani SA; Danis T; Delledonne M; Dougherty MJ; Dudley JT; Faucett WA; Friedman JR; Haase DH; Hays TS; Heilsberg S; Huber J; Kaminsky L; Ledbetter N; Lee WH; Levin E; Libiger O; Linderman M; Love RL; Magnus DC; Martland A; McClure SL; Megill SE; Messier H; Nussbaum RL; Palaniappan L; Patay BA; Popovich BW; Quackenbush J; Savant MJ; Su MM; Terry SF; Tucker S; Wong WT; Green RC
    Expert Rev Mol Diagn; 2016; 16(5):521-32. PubMed ID: 26810587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public Funding for Genomics and the Return on Investment: A Public Health Perspective.
    Hyder A
    Perspect Biol Med; 2018; 61(4):572-583. PubMed ID: 30613039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
    Bombard Y
    Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
    Zaiou M; El Amri H
    Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic medicine: health care issues and the unresolved ethical and social dilemmas.
    Idemyor V
    Am J Ther; 2014; 21(6):548-53. PubMed ID: 22713532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort.
    Swanson KM; Zhu Y; Rojas RL; St Sauver JL; Bielinski SJ; Jacobsen DJ; Visscher SL; Wang L; Weinshilboum R; Borah BJ
    PLoS One; 2020; 15(5):e0233316. PubMed ID: 32428022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.
    Meckley LM; Gudgeon JM; Anderson JL; Williams MS; Veenstra DL
    Pharmacoeconomics; 2010; 28(1):61-74. PubMed ID: 20014877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized genomic information: preparing for the future of genetic medicine.
    Guttmacher AE; McGuire AL; Ponder B; Stefánsson K
    Nat Rev Genet; 2010 Feb; 11(2):161-5. PubMed ID: 20065954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genomics and personalized medicine].
    Mooser V
    Praxis (Bern 1994); 2014 May; 103(10):567-71. PubMed ID: 24800768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine in the care of the child with congenital heart disease: discovery to application.
    Binesh Marvasti T; D'Alessandro LC; Manase D; Papaz T; Mital S
    Congenit Heart Dis; 2013; 8(3):266-9. PubMed ID: 23601919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision medicine/personalized medicine: a critical analysis of movements in the transformation of biomedicine in the early 21st century.
    Iriart JAB
    Cad Saude Publica; 2019 Mar; 35(3):e00153118. PubMed ID: 30916181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of genomics on the future of medicine and health.
    Mattick JS; Dziadek MA; Terrill BN; Kaplan W; Spigelman AD; Bowling FG; Dinger ME
    Med J Aust; 2014 Jul; 201(1):17-20. PubMed ID: 24999876
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
    Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
    OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ethical and social issues associated with genomic medicine].
    Barazzetti G; Kaufmann A; Benaroyo L
    Praxis (Bern 1994); 2014 May; 103(10):573-7. PubMed ID: 24800769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and personalized medicine: foundations and applications.
    Ginsburg GS; Willard HF
    Transl Res; 2009 Dec; 154(6):277-87. PubMed ID: 19931193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing genome-driven personalized cardiology in clinical practice.
    Pasipoularides A
    J Mol Cell Cardiol; 2018 Feb; 115():142-157. PubMed ID: 29343412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Information management to enable personalized medicine: stakeholder roles in building clinical decision support.
    Downing GJ; Boyle SN; Brinner KM; Osheroff JA
    BMC Med Inform Decis Mak; 2009 Oct; 9():44. PubMed ID: 19814826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.